Tight glycemic control and cardiovascular effects in type 2 diabetic patients

Heart Views : the Official Journal of the Gulf Heart Association
Latha Subramanya MoodahaduRamesh Katipally

Abstract

Diabetes Mellitus (DM) with poor glycemic control is one of the leading causes for cardiovascular mortality in diabetic patients. Tight glycemic control with glycosylated haemoglobin of <7 gms% is recommended as a routine and < 6.5 gms% is recommended for young and newly diagnosed diabetics. Treatment goal aims at achieving near normal blood glucose level, and directed at management of other co morbid conditions such as obesity, hypertension and dyslipidemia. Oral hypoglycemic agents are the preferred drugs, alone or in combination. Preference for glitazones is declining due to the increasing evidences of associated adverse events. Gliptins appear as promising agents with lesser tendency to cause hypoglycemia, but their long term safety and efficacy is yet to be established. We emphasize the role of preventive measures in prediabetics and in established DM, treatment should be individualized and customized to minimize hypoglycemic effects and to retain quality of life.

Citations

May 19, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Usharani ThirunavukkarasuKumar Janardanan
Jul 8, 2017·BMC Complementary and Alternative Medicine·Uriel ElyasiyanTovit Rosenzweig
Nov 19, 2020·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Bonisiwe MbathaPhikelelani Ngubane
Jun 4, 2021·ClinicoEconomics and Outcomes Research : CEOR·Lucrezia FerrarioEmanuela Foglia
Jul 3, 2021·Journal of Clinical Medicine·Muhammad Abu TailakhVictor Novack
Aug 14, 2021·Journal of Pharmacological Sciences·Yoichi SunagawaTatsuya Morimoto

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
coronary artery bypass

Software Mentioned

ACCORD
ADVANCE
Google Scholar

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.